Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
May 3, 2007
Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discovery of an unusual structure-activity relationship
Zakaria Rachid, Fouad Brahimi, Qiyu Qiu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 26, 1999
Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines
B J Jean-Claude, A Mustafa, A J Watson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2004
The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo
Stephanie L Matheson, James P McNamee, Taiqui Wang, et al.
Cancers
|
July 13, 2024
Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression
Elvis Martinez-Jaramillo, Fatemeh Jamali, Farah H Abdalbari, et al.
International Journal of Cancer
|
September 24, 2004
Multiple mechanisms of action of ZR2002 in human breast cancer cells: a novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA
Fouad Brahimi, Zakaria Rachid, Qiyu Qiu, et al.
Bioinorganic Chemistry and Applications
|
July 31, 2010
Antineoplastic Activity of New Transition Metal Complexes of 6-Methylpyridine-2-carbaldehyde-N(4)-ethylthiosemicarbazone: X-Ray Crystal Structures of [VO(2)(mpETSC)] and [Pt(mpETSC)Cl]
Shadia A Elsayed, Ahmed M El-Hendawy, Sahar I Mostafa, et al.
Chemical Biology & Drug Design
|
September 5, 2012
Biological effects of AL622, a molecule rationally designed to release an EGFR and a c-Src kinase inhibitor
Anne-Laure Larroque-Lombard, Na Ning, Suman Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2007
The combi-targeting concept: in vitro and in vivo fragmentation of a stable combi-nitrosourea engineered to interact with the epidermal growth factor receptor while remaining DNA reactive
Qiyu Qiu, Juozas Domarkas, Ranjita Banerjee, et al.
Cells
|
March 29, 2023
Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model
Caterina Facchin, Ana B Fraga-Timiraos, Julie Schmitt, et al.
The Journal of Surgical Research
|
January 25, 2000
Metalloproteinase levels are decreased in symptomatic carotid plaques
C D Hower, M S Dassow, A Kajdacsy-Balla, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
May 3, 2007
Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discovery of an unusual structure-activity relationship
Zakaria Rachid, Fouad Brahimi, Qiyu Qiu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 26, 1999
Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines
B J Jean-Claude, A Mustafa, A J Watson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2004
The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo
Stephanie L Matheson, James P McNamee, Taiqui Wang, et al.
Cancers
|
July 13, 2024
Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression
Elvis Martinez-Jaramillo, Fatemeh Jamali, Farah H Abdalbari, et al.
International Journal of Cancer
|
September 24, 2004
Multiple mechanisms of action of ZR2002 in human breast cancer cells: a novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA
Fouad Brahimi, Zakaria Rachid, Qiyu Qiu, et al.
Bioinorganic Chemistry and Applications
|
July 31, 2010
Antineoplastic Activity of New Transition Metal Complexes of 6-Methylpyridine-2-carbaldehyde-N(4)-ethylthiosemicarbazone: X-Ray Crystal Structures of [VO(2)(mpETSC)] and [Pt(mpETSC)Cl]
Shadia A Elsayed, Ahmed M El-Hendawy, Sahar I Mostafa, et al.
Chemical Biology & Drug Design
|
September 5, 2012
Biological effects of AL622, a molecule rationally designed to release an EGFR and a c-Src kinase inhibitor
Anne-Laure Larroque-Lombard, Na Ning, Suman Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2007
The combi-targeting concept: in vitro and in vivo fragmentation of a stable combi-nitrosourea engineered to interact with the epidermal growth factor receptor while remaining DNA reactive
Qiyu Qiu, Juozas Domarkas, Ranjita Banerjee, et al.
Cells
|
March 29, 2023
Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model
Caterina Facchin, Ana B Fraga-Timiraos, Julie Schmitt, et al.
The Journal of Surgical Research
|
January 25, 2000
Metalloproteinase levels are decreased in symptomatic carotid plaques
C D Hower, M S Dassow, A Kajdacsy-Balla, et al.
Page
of 8